Notably, there were slight differences in the anticancer effects between HSC-3 cells and SAS cells, although these two cell lines share some characteristics, i.e., originated from human tongue cancer and have high expression of EGFR, whereas neither has a mutation and are often used as xenograft models. The gene discussed is EGFR; the disease is tongue cancer.